Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Endeavour Silver Corp (EXK) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Endeavour Silver CorpTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Endeavour Silver Corp vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Endeavour Silver Corp trades at $8.73 (market cap $2.46B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.44 (market cap $5.85B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 2.4× Endeavour Silver Corp's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Endeavour Silver Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 25 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

EXKIOVA
Market Cap
$2.46B$5.85B
Volume
5,827,66514,517,176
Sector
Basic MaterialsHealth
52-Week High
$14.12$14.82
52-Week Low
$7.07$1.81
Typical Hold Time
25 Days0 Days
Enterprise Value
$2.47B$5.78B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Endeavour Silver Corp

Endeavour Silver (EXK) trades at $8.32, down 4.04% on the day, amid a bearish technical signal. The company reported a net loss of $119.1M in 2025 but expects a significant turnaround in 2026 with projected net income of $66M. Recent news highlights operational progress at the Terronera and Kolpa mines, though temporary disruptions have occurred. Analyst consensus is strongly bullish with a $10.50 price target, but technical indicators show selling pressure.

The outlook is mixed: strong analyst support and projected profitability in 2026 present upside, but near-term technical weakness and operational risks like mine blockades pose challenges. The stock's valuation multiples are elevated relative to current earnings, requiring successful execution of growth plans to justify further gains.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXK
100% Buy0% Sell
Avg holding period · 25 Days
IOVA
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Endeavour Silver Corp

Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.

Read more on EXK →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →